March 23, 2026 · Form 4 insider transaction
Gibson Christopher sold 40,000 shares of Recursion Pharmaceuticals Inc at $3.25 per share, a transaction worth $130.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.